Global Patient Derived Xenograft (PDX) Models Market Report 2024

Patient Derived Xenograft (PDX) Models Global Market Report 2024 – By Type (Mice Models, Rat Models), By Technique (Heterotopic Implantation, Orthotropic Implantation), By Tumor Type (Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models), By Application (Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research), By End-User (Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Patient Derived Xenograft (PDX) Models Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Patient Derived Xenograft (PDX) Models Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Patient Derived Xenograft (PDX) Models Market Definition

Patient-derived xenograft (PDX) models involve transplanting human tumor tissue into immunodeficient animal hosts. They mimic the complexity of human tumors more closely than traditional cell line models. PDX models are crucial for studying tumor biology and testing potential cancer therapies before clinical trials.

The main types in the patient derived xenograft (PDX) models market are mice models and rat models. Mice models refer to laboratory mice genetically modified or bred to study specific biological processes, diseases, or responses to treatments, aiding in biomedical and pharmaceutical research. The various techniques including heterotopic implantation and orthotropic implantation, and several types of tumors including gastrointestinal tumor models, lung tumor models, hematological tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, and others. PDX models find application in preclinical drug development, precision medicine, co-clinical trials, and basic cancer research across academic institutions, research organizations, pharmaceuticals, biotechnology firms, and others.

Patient Derived Xenograft (PDX) Models Market Segmentation

The patient derived xenograft (PDX) models market covered in this report is segmented –

1) By Type: Mice Models, Rat Models

2) By Technique: Heterotopic Implantation, Orthotropic Implantation

3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models

4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research

5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users

Global Patient Derived Xenograft (PDX) Models Market Size 2023 to 2028: Graph

Patient Derived Xenograft (PDX) Models Market Size 2024 And Growth Rate

The patient derived xenograft (PDX) models market size has grown rapidly in recent years. It will grow from $0.35 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 16%. The growth in the historic period can be attributed to research & development investments, regulatory support, partnerships and collaborations, increasing number of contract research organizations (CROs), and rising number of cancer cases.

Patient Derived Xenograft (PDX) Models Market Growth Forecast

The patient derived xenograft (PDX) models market size is expected to see rapid growth in the next few years. It will grow to $0.74 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to demand for personalized medicine, rising in demand for humanized PDX models, growing incidence of cancer, focus on precision oncology, and increasing R&D investment for cancer research. Major trends in the forecast period include technological developments, rising demand for humanized PDX models, collaborative research initiatives, growing investments in cancer research, and increasing focus on immuno-oncology.

Patient Derived Xenograft (PDX) Models Market Driver: Personalized Medicine's Impact On The PDX Models Market

The demand for personalized medicine is expected to propel the growth of the patient-derived xenograft (PDX) models market going forward. Personalized medicine involves tailoring medical treatment to each patient's specific characteristics, considering factors such as genetics, environment, and lifestyle. The demand for personalized medicine is increasing due to advancements in genomic research, which enable tailored treatments based on individual genetic profiles, leading to more effective and targeted healthcare outcomes. Patient-derived xenograft (PDX) models aid personalized medicine by allowing the testing of individual patient tumors to predict treatment responses and tailor therapies accordingly. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit umbrella organization, in 2023, the FDA approved 16 new personalized treatments for rare diseases, a significant increase from six approvals in 2022. Therefore, the demand for personalized medicine drives the patient-derived xenograft (PDX) models market growth.

Global Patient Derived Xenograft (PDX) Models Market Major Players

Major companies operating in the patient derived xenograft (PDX) models market are Laboratory Corporation of America Holdings, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., The Jackson Laboratory, Inotiv Inc, Biocytogen Pharmaceuticals Co. Ltd., Taconic Biosciences Inc, BioDuro-Sundia Inc, Horizon Discovery Ltd., Crown Bioscience Inc., Champions Oncology Inc., Oncodesign Services S.A, Genesis Biotechnology Group LLC., Creative Animodel, Abnova Corp., Certis Oncology Solutions Inc., Xentech, Aragen Bioscience Inc., EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH., Urosphere, Hera BioLabs, InnoSer , Pharmatest Services Ltd., IVRS AB, Altogen Inc

Global Patient Derived Xenograft (PDX) Models Market Trend: Advancements in Patient-Derived Xenograft (PDX) Models and Bioluminescence Imaging for Glioblastoma Research

Major companies operating in the patient-derived xenograft (PDX) models market are developing innovative models with in vivo bioluminescence imaging capabilities to enable real-time monitoring of tumor growth. In vivo bioluminescence imaging helps PDX models by enabling non-invasive real-time monitoring of tumor metastasis and treatment responses, enhancing the effectiveness of preclinical research in drug development. For instance, in March 2024, InVitro Research Solutions Private Limited, an India-based Contract Research Organization (CRO), launched an innovative orthotopic model of human glioblastoma in NSG-SGM3 mice by using patient-derived xenografts (PDX) and in vivo bioluminescence imaging. This model aims to enable personalized treatment of glioblastoma, the most common and aggressive type of brain cancer. These models are critical for understanding glioblastoma biology and evaluating new targeted therapies and immunotherapies to improve outcomes.

Patient Derived Xenograft (PDX) Models Market Merger And Acquisition: Acquisition of Envigo RMS Holding Corp. By Inotiv Inc. Strengthens Research Services Offering

In November 2021, Inotiv Inc., a US-based provider of nonclinical and analytical drug discovery development services, research models, and related products and services, acquired Envigo RMS Holding Corp. for $271 million. The company aims to improve efficiency, reduce lead times, and offer various research models and services. Envigo RMS Holding Corp. is a US-based provider of research models and services.

Regional Insights For The Global Patient Derived Xenograft (PDX) Models Market

North America was the largest region in the patient derived xenograft (PDX) models market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient derived xenograft (PDX) models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient derived xenograft (PDX) models market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient derived xenograft (PDX) models market includes revenues earned by entities by providing services such as evaluating drug efficacy, studying tumor biology, and predicting patient-specific treatment responses in preclinical cancer research. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The patient derived xenograft (PDX) models market research report is one of a series of new reports from The Business Research Company that provides patient derived xenograft (PDX) models market statistics, including the patient derived xenograft (PDX) models industry global market size, regional shares, competitors with patient derived xenograft (PDX) models market share, detailed patient derived xenograft (PDX) models market segments, market trends, and opportunities, and any further data you may need to thrive in the patient derived xenograft (PDX) models industry. These patient derived xenograft (PDX) models market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Patient Derived Xenograft (PDX) Models Market Report Forecast and Analysis
Report AttributeDetails
Market Size Value In 2024 $0.4 billion
Revenue Forecast In 2033 $0.74 billion
Growth Rate CAGR of 16.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Mice Models, Rat Models
2) By Technique: Heterotopic Implantation, Orthotropic Implantation
3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models
4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research
5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Laboratory Corporation of America Holdings, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., The Jackson Laboratory, Inotiv Inc, Biocytogen Pharmaceuticals Co. Ltd., Taconic Biosciences Inc, BioDuro-Sundia Inc, Horizon Discovery Ltd., Crown Bioscience Inc., Champions Oncology Inc., Oncodesign Services S.A, Genesis Biotechnology Group LLC., Creative Animodel, Abnova Corp., Certis Oncology Solutions Inc., Xentech, Aragen Bioscience Inc., EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH., Urosphere, Hera BioLabs, InnoSer , Pharmatest Services Ltd., IVRS AB, Altogen Inc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Patient Derived Xenograft (PDX) Models Market Characteristics

    3. Patient Derived Xenograft (PDX) Models Market Trends And Strategies

    4. Patient Derived Xenograft (PDX) Models Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Patient Derived Xenograft (PDX) Models Market Size and Growth

    5.1. Global Patient Derived Xenograft (PDX) Models Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Patient Derived Xenograft (PDX) Models Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Patient Derived Xenograft (PDX) Models Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Patient Derived Xenograft (PDX) Models Market Segmentation

    6.1. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Mice Models

    Rat Models

    6.2. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Heterotopic Implantation

    Orthotropic Implantation

    6.3. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gastrointestinal Tumor Models

    Lung Tumor Models

    Hematological Tumor Models

    Gynecological Tumor Models

    Respiratory Tumor Models

    Urological Tumor Models

    Other Tumor Models

    6.4. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Preclinical Drug Development

    Precision Medicine

    Co-Clinical Trials

    Basic Cancer Research

    6.5. Global Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Academic And Research Organizations

    Contract Research Organizations

    Pharmaceutical And Biotechnological Companies

    Other End-Users

    7. Patient Derived Xenograft (PDX) Models Market Regional And Country Analysis

    7.1. Global Patient Derived Xenograft (PDX) Models Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Patient Derived Xenograft (PDX) Models Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Patient Derived Xenograft (PDX) Models Market

    8.1. Asia-Pacific Patient Derived Xenograft (PDX) Models Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Patient Derived Xenograft (PDX) Models Market

    9.1. China Patient Derived Xenograft (PDX) Models Market Overview

    9.2. China Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Patient Derived Xenograft (PDX) Models Market

    10.1. India Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Patient Derived Xenograft (PDX) Models Market

    11.1. Japan Patient Derived Xenograft (PDX) Models Market Overview

    11.2. Japan Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Patient Derived Xenograft (PDX) Models Market

    12.1. Australia Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Patient Derived Xenograft (PDX) Models Market

    13.1. Indonesia Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Patient Derived Xenograft (PDX) Models Market

    14.1. South Korea Patient Derived Xenograft (PDX) Models Market Overview

    14.2. South Korea Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Patient Derived Xenograft (PDX) Models Market

    15.1. Western Europe Patient Derived Xenograft (PDX) Models Market Overview

    15.2. Western Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Patient Derived Xenograft (PDX) Models Market

    16.1. UK Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Patient Derived Xenograft (PDX) Models Market

    17.1. Germany Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Patient Derived Xenograft (PDX) Models Market

    18.1. France Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Patient Derived Xenograft (PDX) Models Market

    19.1. Italy Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Patient Derived Xenograft (PDX) Models Market

    20.1. Spain Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Patient Derived Xenograft (PDX) Models Market

    21.1. Eastern Europe Patient Derived Xenograft (PDX) Models Market Overview

    21.2. Eastern Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Patient Derived Xenograft (PDX) Models Market

    22.1. Russia Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Patient Derived Xenograft (PDX) Models Market

    23.1. North America Patient Derived Xenograft (PDX) Models Market Overview

    23.2. North America Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Patient Derived Xenograft (PDX) Models Market

    24.1. USA Patient Derived Xenograft (PDX) Models Market Overview

    24.2. USA Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Patient Derived Xenograft (PDX) Models Market

    25.1. Canada Patient Derived Xenograft (PDX) Models Market Overview

    25.2. Canada Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Patient Derived Xenograft (PDX) Models Market

    26.1. South America Patient Derived Xenograft (PDX) Models Market Overview

    26.2. South America Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Patient Derived Xenograft (PDX) Models Market

    27.1. Brazil Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Patient Derived Xenograft (PDX) Models Market

    28.1. Middle East Patient Derived Xenograft (PDX) Models Market Overview

    28.2. Middle East Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Patient Derived Xenograft (PDX) Models Market

    29.1. Africa Patient Derived Xenograft (PDX) Models Market Overview

    29.2. Africa Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Patient Derived Xenograft (PDX) Models Market Competitive Landscape And Company Profiles

    30.1. Patient Derived Xenograft (PDX) Models Market Competitive Landscape

    30.2. Patient Derived Xenograft (PDX) Models Market Company Profiles

    30.2.1. Laboratory Corporation of America Holdings

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. WuXi AppTec Co. Ltd.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Charles River Laboratories International Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. The Jackson Laboratory

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Inotiv Inc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Patient Derived Xenograft (PDX) Models Market Other Major And Innovative Companies

    31.1. Biocytogen Pharmaceuticals Co. Ltd.

    31.2. Taconic Biosciences Inc

    31.3. BioDuro-Sundia Inc

    31.4. Horizon Discovery Ltd.

    31.5. Crown Bioscience Inc.

    31.6. Champions Oncology Inc.

    31.7. Oncodesign Services S.A

    31.8. Genesis Biotechnology Group LLC.

    31.9. Creative Animodel

    31.10. Abnova Corp.

    31.11. Certis Oncology Solutions Inc.

    31.12. Xentech

    31.13. Aragen Bioscience Inc.

    31.14. EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH.

    31.15. Urosphere

    32. Global Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking

    33. Global Patient Derived Xenograft (PDX) Models Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Patient Derived Xenograft (PDX) Models Market

    35. Patient Derived Xenograft (PDX) Models Market Future Outlook and Potential Analysis

    35.1 Patient Derived Xenograft (PDX) Models Market In 2028 - Countries Offering Most New Opportunities

    35.2 Patient Derived Xenograft (PDX) Models Market In 2028 - Segments Offering Most New Opportunities

    35.3 Patient Derived Xenograft (PDX) Models Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Patient Derived Xenograft (PDX) Models Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global Patient Derived Xenograft (PDX) Models Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: Laboratory Corporation of America Holdings Financial Performance
  • Table 77: WuXi AppTec Co. Ltd. Financial Performance
  • Table 78: Charles River Laboratories International Inc. Financial Performance
  • Table 79: The Jackson Laboratory Financial Performance
  • Table 80: Inotiv Inc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Tumor Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Patient Derived Xenograft (PDX) Models Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global Patient Derived Xenograft (PDX) Models Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, Patient Derived Xenograft (PDX) Models Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: Laboratory Corporation of America Holdings Financial Performance
  • Figure 77: WuXi AppTec Co. Ltd. Financial Performance
  • Figure 78: Charles River Laboratories International Inc. Financial Performance
  • Figure 79: The Jackson Laboratory Financial Performance
  • Figure 80: Inotiv Inc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the patient derived xenograft (PDX) models market?

Patient-derived xenograft (PDX) models involve transplanting human tumor tissue into immunodeficient animal hosts. They mimic the complexity of human tumors more closely than traditional cell line models. PDX models are crucial for studying tumor biology and testing potential cancer therapies before clinical trials. For further insights on the patient derived xenograft (PDX) models market, request a sample here

How will the patient derived xenograft (PDX) models market drivers and restraints affect the patient derived xenograft (PDX) models market dynamics? What forces will shape the patient derived xenograft (PDX) models industry going forward?

The patient derived xenograft (PDX) models market major growth driver - Personalized Medicine's Impact On The PDX Models Market. For further insights on the patient derived xenograft (PDX) models market, request a sample here

What is the forecast market size or the forecast market value of the patient derived xenograft (PDX) models market?

The patient derived xenograft (PDX) models market size has grown rapidly in recent years. It will grow from $0.35 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 16%. The growth in the historic period can be attributed to research & development investments, regulatory support, partnerships and collaborations, increasing number of contract research organizations (CROs), and rising number of cancer cases. The patient derived xenograft (PDX) models market size is expected to see rapid growth in the next few years. It will grow to $0.74 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to demand for personalized medicine, rising in demand for humanized PDX models, growing incidence of cancer, focus on precision oncology, and increasing R&D investment for cancer research. Major trends in the forecast period include technological developments, rising demand for humanized PDX models, collaborative research initiatives, growing investments in cancer research, and increasing focus on immuno-oncology. For further insights on the patient derived xenograft (PDX) models market, request a sample here

How is the patient derived xenograft (PDX) models market segmented?

The patient derived xenograft (PDX) models market is segmented
1) By Type: Mice Models, Rat Models
2) By Technique: Heterotopic Implantation, Orthotropic Implantation
3) By Tumor Type: Gastrointestinal Tumor Models, Lung Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Urological Tumor Models, Other Tumor Models
4) By Application: Preclinical Drug Development, Precision Medicine, Co-Clinical Trials, Basic Cancer Research
5) By End-User: Academic And Research Organizations, Contract Research Organizations, Pharmaceutical And Biotechnological Companies, Other End-UsersFor further insights on the patient derived xenograft (PDX) models market,
request a sample here

Which region has the largest share of the patient derived xenograft (PDX) models market? What are the other regions covered in the report?

North America was the largest region in the patient derived xenograft (PDX) models market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient derived xenograft (PDX) models market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the patient derived xenograft (PDX) models market, request a sample here.

Who are the major players in the patient derived xenograft (PDX) models market?

Major companies operating in the patient derived xenograft (PDX) models market are Laboratory Corporation of America Holdings, WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., The Jackson Laboratory, Inotiv Inc, Biocytogen Pharmaceuticals Co. Ltd., Taconic Biosciences Inc, BioDuro-Sundia Inc , Horizon Discovery Ltd., Crown Bioscience Inc., Champions Oncology Inc., Oncodesign Services S.A, Genesis Biotechnology Group LLC., Creative Animodel, Abnova Corp., Certis Oncology Solutions Inc., Xentech , Aragen Bioscience Inc., EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH., Urosphere , Hera BioLabs, InnoSer , Pharmatest Services Ltd., IVRS AB, Altogen Inc For further insights on the patient derived xenograft (PDX) models market, request a sample here.

What are the key trends in the patient derived xenograft (PDX) models market?

Major trend in the patient derived xenograft (PDX) models market - Advancements in Patient-Derived Xenograft (PDX) Models and Bioluminescence Imaging for Glioblastoma Research. For further insights on the patient derived xenograft (PDX) models market, request a sample here.

What are the major opportunities in the patient derived xenograft (PDX) models market? What are the strategies for the patient derived xenograft (PDX) models market?

For detailed insights on the major opportunities and strategies in the patient derived xenograft (PDX) models market, request a sample here.

How does the patient derived xenograft (PDX) models market relate to the overall economy and other similar markets?

For detailed insights on patient derived xenograft (PDX) models market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the patient derived xenograft (PDX) models industry?

For detailed insights on the mergers and acquisitions in the patient derived xenograft (PDX) models industry, request a sample here.

What are the key dynamics influencing the patient derived xenograft (PDX) models market growth? SWOT analysis of the patient derived xenograft (PDX) models market.

For detailed insights on the key dynamics influencing the patient derived xenograft (PDX) models market growth and SWOT analysis of the patient derived xenograft (PDX) models industry, request a sample here.